Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-12-18

FDA Approved: ORGOVYX — Original Application (Sumitomo Pharma America, Inc.)

View source ↗

Summary

The FDA approved ORGOVYX (relugolix) under an original NDA submitted by Sumitomo Pharma America, marking the approval of a new treatment option for advanced pro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ORGOVYX (RELUGOLIX)

Snippet

ORIG AP for ORGOVYX (RELUGOLIX)